| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3850555 | American Journal of Kidney Diseases | 2008 | 11 Pages |
Abstract
Black patients were administered approximately 12% greater EPO doses than white patients while achieving similar hemoglobin levels. We identified variables that differed across race that may explain this difference, but they were either not actionable or presented limited opportunity for intervention. Additional studies are needed to define a physiological (or pathological) basis for these observations.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Eduardo MD, MPH, FASN, John ScD, Ming MD, J. Michael MD, Raymond M. MD, PhD,